GGrantIndex
← Leaderboards

Christopher J Lyon

Tulane University Of Louisiana

$5,706,710
Attributed
$6,932,117
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY201925
$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,932,117 · 3

By mechanism

R01$6,752,232 · 2
R21$179,885 · 1

Top collaborators

Most similar at Tulane University Of Louisiana

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Monitor

Research focus

MonitorEvaluationPerformanceChildhoodChildSerumTuberculosisValidationDiagnosticDiagnosisTreatment ResponseBiological MarkersMycobacterium TuberculosisSamplingMycobacterialEnrollmentImmune ResponseMass Spectrum AnalysisCohortPredictive ModelingBacillusAdultAntitubercular AgentsProteomics

Grant awards (13)

Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP$708,809
R01 · FY2025 · HD · contact PI
Detecting pathogen and host factors on extracellular vesicles for pediatric TB diagnosis and management$513,222
R01 · FY2025 · HD
Detecting pathogen and host factors on extracellular vesicles for pediatric TB diagnosis and management$92,669
R01 · FY2025 · HD
Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP$720,969
R01 · FY2024 · HD · contact PI
Detecting pathogen and host factors on extracellular vesicles for pediatric TB diagnosis and management$599,830
R01 · FY2024 · HD
Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP$731,611
R01 · FY2023 · HD · contact PI
Detecting pathogen and host factors on extracellular vesicles for pediatric TB diagnosis and management$632,390
R01 · FY2023 · HD
Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP$741,321
R01 · FY2022 · HD · contact PI
Direct quantitation of the circulating Mtb-peptidome for pediatric TB management$386,773
R01 · FY2022 · HD · contact PI
Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP$790,427
R01 · FY2021 · HD · contact PI
Direct quantitation of the circulating Mtb-peptidome for pediatric TB management$408,551
R01 · FY2021 · HD · contact PI
Mobile based Nanoplasmonic Quantification of Mtb-derived Exosomes in Serum for Pediatric TB diagnosis$179,885
R21 · FY2020 · EB · contact PI
Direct quantitation of the circulating Mtb-peptidome for pediatric TB management$425,660
R01 · FY2019 · HD · contact PI